A proven process for investigators will be presented to address common deficiencies with respect to costs associated with clinical investigator site requirements for studay conduct.
How to identify ALL of the indirect costs?
How to identify fixed costs?
What are the appropriate profit factors for each category?
How to estimate costs for delays in starting, cash flow, amendments etc?
Contract negotiation skills.
Investigator contract requirements that must be present.
Investigator contract requirements that are negotiable.
Metrics as a contract performance tool.
Why Should You Attend:
Clinical trial conduct contains many clinical investigator direct and indirect costs that are often not included by investigators in their budgets and contract negotiations. As an example- Profit (and the relevant tax burden) is often not included as an investigator cost. Many clinical trials are conducted at the investigator site to terms dictated by the sponsor contract that do not necessarily reflect clinical investigator site requirements for study conduct. An inappropriate contract creates additional costs for the investigator when this occurs. These costs generate performance challenges for both sponsor and investigator.Areas Covered in the seminar:
How to identify ALL of the direct costs?How to identify ALL of the indirect costs?
How to identify fixed costs?
What are the appropriate profit factors for each category?
How to estimate costs for delays in starting, cash flow, amendments etc?
Contract negotiation skills.
Investigator contract requirements that must be present.
Investigator contract requirements that are negotiable.
Metrics as a contract performance tool.
- Managing the contract as a tool to enable project success
Who Will Benefit:
- Sponsor program managers
- Sponsor CRA’s
- Investigators
- CRC Managers
Course Provider
Stephen Schwartz,
